3603 Management of unresectable metastatic colorectal cancer (MRCC) in the real world with successive regimens with targeted therapies (Bevacizumab and cetuximab): the experience of the OMIT Bretagne Pays de Loire

Metges, J.P ; Gamelin, E ; Faroux, R ; Klein, V ; Ganem, G ; Douillard, J.Y ; Stampfli, C ; Corbinais, S ; Riche, C ; Grude, F

European journal of cancer supplements, 2009, Vol.7 (2), p.209-209 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível